Express News | Sellas Shares up 3.8% After Co Reports Preclinical Data for Blood Cancer Drug
Express News | Sellas: Asxl1 Mutations Predictably Identified in Colorectal Cancer and Non-Small Cell Lung Cancer in Addition to Hematologic Malignancies
Express News | Sellas Life Sciences Group Inc: Preselection Method for Cancers Responding to Sls009
Express News | Sellas Announces Positive Data From Preclinical Studies Indicating Asxl1 Mutations as Predictor of Response to Sls009 in Solid Cancers
SELLAS Announces Positive Data From Preclinical Studies Indicating ASXL1 Mutations as Predictor of Response to SLS009 in Solid Cancers
We're A Little Worried About SELLAS Life Sciences Group's (NASDAQ:SLS) Cash Burn Rate